{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:43:26Z","timestamp":1791859406362,"version":"4.3.4"},"reference-count":97,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)"},{"name":"Funda\u00e7\u00e3o de Amparo `a Pesquisa do Estado de Minas Gerais (FAPEMIG)"},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Doen\u00e7as Tropicais (INCT-DT)"},{"name":"National Institutes of Health (NIH)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>American Tegumentary Leishmaniasis (ATL), caused by parasites of the genus Leishmania, presents a significant global health challenge, especially in Brazil, where cutaneous and mucosal forms are highly prevalent. Cutaneous Leishmaniasis (CL) typically results in single lesions, while mucosal Leishmaniasis (ML) leads to destructive mucosal lesions with a worse prognosis. The immune response, regulated by cytokines, plays a crucial role in disease progression and resolution. In CL, a balance between pro-inflammatory and anti-inflammatory cytokines is associated with lesion resolution, whereas in ML, an exaggerated inflammatory response worsens tissue damage. Thus, understanding cytokine regulation is essential for unveiling disease pathology and developing effective immunotherapeutic strategies. Here we discuss gene polymorphisms and epigenetic modifications that affect cytokine expression, influencing disease susceptibility and severity, as well as immunotherapeutic approaches that involve cytokine function in Leishmaniasis. In addition, we examine advancements in drug discovery, utilizing in silico methods and targeted drug delivery systems, providing potential avenues for better therapeutic interventions. Continuous research into immune responses and cytokine production and function is critical for identifying novel therapeutic targets and optimizing patient care for ATL.<\/jats:p>","DOI":"10.3390\/pathogens14020188","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T05:10:22Z","timestamp":1739423422000},"page":"188","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cytokine Networks and the Clinical Outcome of American Teg-Umentary Leishmaniasis: Unveiling Targets for Alternative Therapeutic Interventions"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8922-1667","authenticated-orcid":false,"given":"Carolina Cattoni","family":"Koh","sequence":"first","affiliation":[{"name":"Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Av. Pres. Ant\u00f4nio Carlos, 6627-Pampulha, Belo Horizonte 31270-901, MG, Brazil"},{"name":"National Institute of Science and Technology in Tropical Diseases, INCT-DT, Salvador 40110-160, BA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4184-3867","authenticated-orcid":false,"given":"Kenneth J.","family":"Gollob","sequence":"additional","affiliation":[{"name":"National Institute of Science and Technology in Tropical Diseases, INCT-DT, Salvador 40110-160, BA, Brazil"},{"name":"Hospital Israelita Albert Einstein, S\u00e3o Paulo 05652-900, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-9996","authenticated-orcid":false,"given":"Walderez O.","family":"Dutra","sequence":"additional","affiliation":[{"name":"Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Av. Pres. Ant\u00f4nio Carlos, 6627-Pampulha, Belo Horizonte 31270-901, MG, Brazil"},{"name":"National Institute of Science and Technology in Tropical Diseases, INCT-DT, Salvador 40110-160, BA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0140-6736(18)33057-5","article-title":"Leishmaniasis\u2014Authors\u2019 reply","volume":"393","author":"Burza","year":"2019","journal-title":"Lancet"},{"key":"ref_2","unstructured":"(2024, February 06). Situa\u00e7\u00e3o Epidemiol\u00f3gica da LT\u2014Minist\u00e9rio da Sa\u00fade, Available online: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/saude-de-a-a-z\/l\/lt\/situacao-epidemiologica."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/trstmh\/try075","article-title":"The rise of leishmaniasis in the twenty-first century","volume":"112","author":"Hotez","year":"2018","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_4","first-page":"71","article-title":"Leishmaniose tegumentar americana American cutaneous leishmaniasis","volume":"36","author":"Gontijo","year":"2003","journal-title":"Med. Trop."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Guerra, J.A.d.O., Prestes, S.R., Silveira, H., Coelho, L.I.d.A.R.C., Gama, P., Moura, A., Amato, V., Barbosa, M.d.G.V., and Ferreira, L.C.d.L. (2011). Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon. PLoS Negl. Trop. Dis., 5.","DOI":"10.1371\/journal.pntd.0000980"},{"key":"ref_6","first-page":"279","article-title":"Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis","volume":"57","author":"Castes","year":"1984","journal-title":"Clin. Exp. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4269\/ajtmh.2001.65.87","article-title":"Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony","volume":"65","author":"Lessa","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/trstmh\/trz037","article-title":"What makes mucosal and anergic diffuse cutaneous leishmaniases so clinically and immunopathogically different? A review in Brazil","volume":"113","author":"Silveira","year":"2019","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/qjmed\/hct116","article-title":"Leishmaniasis: Clinical syndromes and treatment","volume":"107","author":"Mcgwire","year":"2014","journal-title":"QJM Int. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: Immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4236\/ojas.2021.113029","article-title":"The Role of Neutrophils in the Interaction with Leishmania: Far beyond a Simple Trojan Horse?","volume":"11","author":"Carreira","year":"2021","journal-title":"Open J. Anim. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1073\/pnas.0900226106","article-title":"Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps","volume":"106","author":"Nascimento","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.4049\/jimmunol.173.11.6521","article-title":"Cutting Edge: Neutrophil Granulocyte Serves as a Vector for Leishmania Entry into Macrophages","volume":"173","author":"Klinger","year":"2004","journal-title":"J. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.177.6.1797","article-title":"Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type 1 immune response","volume":"177","author":"Sypek","year":"1993","journal-title":"J. Exp. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-3083.1999.00554.x","article-title":"Interferon-\u03b3 and tumour necrosis factor-\u03b1-producing cells in humans who are immune to cutaneous leishmaniasis","volume":"49","author":"Kemp","year":"1999","journal-title":"Scand. J. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2795090","DOI":"10.1155\/2016\/2795090","article-title":"The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases","volume":"2016","author":"Tan","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Carneiro, P.P., Concei\u00e7\u00e3o, J., Macedo, M., Magalh\u00e3es, V., Carvalho, E.M., and Bacellar, O. (2016). The role of nitric oxide and reactive oxygen species in the killing of leishmania braziliensis by monocytes from patients with cutaneous leishmaniasis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0148084"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/infdis\/jiu013","article-title":"Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species","volume":"209","author":"Novais","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.humimm.2009.01.007","article-title":"Th1\/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-\u03b3 production","volume":"70","author":"Castellano","year":"2009","journal-title":"Hum. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4269\/ajtmh.1995.53.256","article-title":"Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis","volume":"53","author":"Barral","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4269\/ajtmh.1992.47.587","article-title":"Lymphadenopathy associated with Leishmania braziliensis cutaneous infection","volume":"47","author":"Barral","year":"1992","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.imlet.2003.09.001","article-title":"Adhesion molecule expression patterns indicate activation and recruitment of CD4+ T cells from the lymph node to the peripheral blood of early cutaneous leishmaniasis patients","volume":"90","author":"Costa","year":"2003","journal-title":"Immunol. Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4269\/ajtmh.16-0539","article-title":"Characterization of the histopathologic features in patients in the early and late phases of cutaneous leishmaniasis","volume":"96","author":"Saldanha","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4269\/ajtmh.2009.80.574","article-title":"Association of Treatment of American Cutaneous Leishmaniasis Prior to Ulcer Development with High Rate of Failure in Northeastern Brazil","volume":"80","author":"Unger","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/20477724.2016.1232042","article-title":"Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: A review","volume":"110","author":"Maspi","year":"2016","journal-title":"Pathog. Glob. Health"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2249.2007.03436.x","article-title":"Can interferon-\u03b3 and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?","volume":"149","author":"Bittar","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev-immunol-101921-041206","article-title":"IL-4 and IL-13: Regulators and Effectors of Wound Repair","volume":"41","author":"Allen","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/ni.1671","article-title":"Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens","volume":"9","author":"Qualls","year":"2008","journal-title":"Nat. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Costa, D.L., Carregaro, V., Lima-J\u00fanior, D.S., Silva, N.M., Milanezi, C.M., Cardoso, C.R., Giudice, \u00c2., de Jesus, A.R., Carvalho, E.M., and Almeida, R.P. (2011). BALB\/c Mice Infected with Antimony Treatment Refractory Isolate of Leishmania braziliensis Present Severe Lesions due to IL-4 Production. PLoS Negl. Trop. Dis., 5.","DOI":"10.1371\/journal.pntd.0000965"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cyto.2013.12.016","article-title":"The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis","volume":"66","author":"Oliveira","year":"2014","journal-title":"Cytokine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1529-8019.2009.01272.x","article-title":"Cutaneous and mucocutaneous leishmaniasis","volume":"22","author":"David","year":"2009","journal-title":"Dermatol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1128\/IAI.70.12.6734-6740.2002","article-title":"Up-regulation of Th1-type responses in mucosal leishmaniasis patients","volume":"70","author":"Bacellar","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-3024.2007.00940.x","article-title":"Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis","volume":"29","author":"Carvalho","year":"2007","journal-title":"Parasite Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-3083.2005.01707.x","article-title":"Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population","volume":"63","author":"Gaze","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-3024.2009.01125.x","article-title":"Recruitment of CD8+ T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis","volume":"31","author":"Faria","year":"2009","journal-title":"Parasite Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7853","DOI":"10.1128\/IAI.73.12.7853-7859.2005","article-title":"Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis","volume":"73","author":"Faria","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Koh, C.C., Wardini, A.B., Vieira, M., Passos, L.S.A., Martinelli, P.M., Neves, E.G.A., Antonelli, L.R.D.V., Barbosa, D.F., Velikkakam, T., and Gutseit, E. (2020). Human CD8+ T Cells Release Extracellular Traps Co-Localized with Cytotoxic Vesicles That Are Associated with Lesion Progression and Severity in Human Leishmaniasis. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.594581"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Bertho, A.L., Santiago, M.A., Da-Cruz, A.M., and Coutinho, S.G. (2000). Detection of early apoptosis and cell death in T CD4+ and CD8+ cells from lesions of patients with localized cutaneous leishmaniasis. Braz. J. Med. Biol. Res., 33.","DOI":"10.1590\/S0100-879X2000000300010"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-0799-x","article-title":"Apoptosis and frequency of total and effector CD8+ T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy","volume":"15","author":"Ferraz","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Novais, F.O., Carvalho, L.P., Graff, J.W., Beiting, D.P., Ruthel, G., Roos, D.S., Betts, M.R., Goldschmidt, M.H., Wilson, M.E., and de Oliveira, C.I. (2013). Cytotoxic T Cells Mediate Pathology and Metastasis in Cutaneous Leishmaniasis. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003504"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/imm.13173","article-title":"Compartmentalized cytotoxic immune response leads to distinct pathogenic roles of natural killer and senescent CD8+ T cells in human cutaneous leishmaniasis","volume":"159","author":"Covre","year":"2020","journal-title":"Immunology"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Egui, A., Ledesma, D., P\u00e9rez-Ant\u00f3n, E., Montoya, A., G\u00f3mez, I., Robledo, S.M., Infante, J.J., V\u00e9lez, I.D., L\u00f3pez, M.C., and Thomas, M.C. (2018). Phenotypic and Functional Profiles of Antigen-Specific CD4+ and CD8+ T Cells Associated with Infection Control in Patients with Cutaneous Leishmaniasis. Front. Cell. Infect. Microbiol., 8.","DOI":"10.3389\/fcimb.2018.00393"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.humimm.2012.04.005","article-title":"Genetic variants in the chemokines and chemokine receptors in Chagas disease","volume":"73","year":"2012","journal-title":"Hum. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF03160478","article-title":"Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious diseases and the septic syndrome","volume":"3","author":"Knight","year":"2001","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.humimm.2019.08.001","article-title":"Human leukocyte antigen-G 3\u2032 untranslated region polymorphism +3142G\/C (rs1063320) and haplotypes are associated with manifestations of the American Tegumentary Leishmaniasis in a Northeastern Brazilian population","volume":"80","author":"Sonon","year":"2019","journal-title":"Hum. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Matos, G.I., Covas, C.d.J.F., Bittar, R.d.C., Gomes-Silva, A., Marques, F., Maniero, V.C., Amato, V.S., Oliveira-Neto, M.P., Mattos, M.d.S., and Pirmez, C. (2007). IFNG +874T\/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmania induced IFN-\u03b3 production. BMC Infect. Dis., 7.","DOI":"10.1186\/1471-2334-7-33"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Mera-Ram\u00edrez, A., Castillo, A., Orobio, Y., G\u00f3mez, M.A., and Gallego-Marin, C. (2017). Screening of TNF\u03b1, IL-10 and TLR4 single nucleotide polymorphisms in individuals with asymptomatic and chronic cutaneous leishmaniasis in Colombia: A pilot study. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2281-4"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Junior, J.D.E.S., de Souza, J.L., da Silva, L.S., da Silva, C.C., Nascimento, T.A.D., de Souza, M.L.G., da Cunha, A.F., Batista, J.d.S., Neto, J.P.d.M., and Guerra, M.V.d.F. (2023). A fine mapping of single nucleotide variants and haplotype analysis of IL13 gene in patients with Leishmania guyanensis-cutaneous leishmaniasis and plasma cytokines IL-4, IL-5, and IL-13. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1232488"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"154784","DOI":"10.1016\/j.cyto.2019.154784","article-title":"Study of association of the rs2275913 IL-17A single nucleotide polymorphism and susceptibility to cutaneous leishmaniasis caused by Leishmania braziliensis","volume":"123","author":"Albuquerque","year":"2019","journal-title":"Cytokine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"154788","DOI":"10.1016\/j.cyto.2019.154788","article-title":"A polymorphism in the IL1B gene (rs16944 T\/C) is associated with cutaneous leishmaniasis caused by Leishmania guyanensis and plasma cytokine interleukin receptor antagonist","volume":"123","author":"Junior","year":"2019","journal-title":"Cytokine"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Santos, F.J.D.A., Da Silva, L.S., J\u00fanior, J.D.E.S., De Mesquita, T.G.R., De Souza, M.L.G., J\u00fanior, M.C.D.A., Talhari, S., and Ramasawmy, R. (2019). Single nucleotide polymorphisms of the genes IL-2, IL-2RB, and JAK3 in patients with cutaneous leishmaniasis caused by Leishmania (V.) guyanensis in Manaus, Amazonas, Brazil. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220572"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.4049\/jimmunol.1402047","article-title":"IL2RA Genetic Variants Reduce IL-2\u2013Dependent Responses and Aggravate Human Cutaneous Leishmaniasis","volume":"194","author":"Oliveira","year":"2015","journal-title":"J. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/505504","article-title":"IL6 -174 G\/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil","volume":"194","author":"Castellucci","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cyto.2012.09.012","article-title":"Candidate gene case-control and functional study shows macrophage inhibitory factor (MIF) polymorphism is associated with cutaneous leishmaniasis","volume":"61","author":"Cardoso","year":"2013","journal-title":"Cytokine"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"de Mesquita, T.G.R., Junior, J.D.E.S., de Souza, J.L., da Silva, L.S., Nascimento, T.A.D., de Souza, M.L.G., Guerra, M.V.d.F., and Ramasawmy, R. (2023). Variants of NOD2 in Leishmania guyanensis-infected patients with cutaneous leishmaniasis and correlations with plasma circulating pro-inflammatory cytokines. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0281814"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e20170415","DOI":"10.1590\/0037-8682-0415-2017","article-title":"Tgf-\u03b21 polymorphism in american tegumentary leishmaniasis in a southern brazilian population","volume":"52","author":"Shehadeh","year":"2019","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"155437","DOI":"10.1016\/j.cyto.2021.155437","article-title":"Meta-analysis of \u2212308G > A polymorphism in TNF\u03b1 gene and susceptibility to leishmaniasis","volume":"140","author":"Ejghal","year":"2021","journal-title":"Cytokine"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"de Araujo, F.J., da Silva, L.D.O., Mesquita, T.G., Pinheiro, S.K., Vital, W.d.S., Chrusciak-Talhari, A., Guerra, J.A.d.O., Talhari, S., and Ramasawmy, R. (2015). Polymorphisms in the TOLLIP gene influence susceptibility to cutaneous leishmaniasis caused by leishmania guyanensis in the amazonas state of Brazil. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003875"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJMra1402513","article-title":"The Key Role of Epigenetics in Human Disease Prevention and Mitigation","volume":"378","author":"Feinberg","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/PPO.0000000000000279","article-title":"The Roles of DNA Methylation in the Stages of Cancer","volume":"23","author":"McMahon","year":"2017","journal-title":"Cancer J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1073\/pnas.0510310103","article-title":"A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters","volume":"103","author":"Saxonov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Alemohammad, H., Najafzadeh, B., Asadzadeh, Z., Baghbanzadeh, A., Ghorbaninezhad, F., Najafzadeh, A., Safarpour, H., Bernardini, R., Brunetti, O., and Sonnessa, M. (2022). The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer. Biomed. Pharmacother., 146.","DOI":"10.1016\/j.biopha.2021.112516"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.gde.2005.08.005","article-title":"How microRNAs control cell division, differentiation and death","volume":"15","author":"Miska","year":"2005","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Fr\u00edas-Lasserre, D., and Villagra, C.A. (2017). The importance of ncRNAs as epigenetic mechanisms in phenotypic variation and organic evolution. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.02483"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Bragato, J.P., Melo, L.M., Venturin, G.L., Rebech, G.T., Garcia, L.E., Lopes, F.L., and de Lima, V.M.F. (2018). Relationship of peripheral blood mononuclear cells miRNA expression and parasitic load in canine visceral Leishmaniasis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0206876"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/pim.12156","article-title":"Characterization of microRNA expression profiles in Leishmania-infected human phagocytes","volume":"37","author":"Geraci","year":"2015","journal-title":"Parasite Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Souza, M.d.A., Ramos-Sanchez, E.M., Muxel, S.M., Lagos, D., Reis, L.C., Pereira, V.R.A., Brito, M.E.F., Zampieri, R.A., Kaye, P.M., and Floeter-Winter, L.M. (2021). miR-548d-3p Alters Parasite Growth and Inflammation in Leishmania (Viannia) braziliensis Infection. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.687647"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Nunes, S., Silva, I.B., Ampuero, M.R., de Noronha, A.L.L., de Souza, L.C.L., Correia, T.C., Khouri, R., Boaventura, V.S., Barral, A., and Ramos, P.I.P. (2018). Integrated analysis reveals that miR-193b, miR-671, and TREM-1 correlate with a good response to treatment of human Localized cutaneous leishmaniasis caused by Leishmania braziliensis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00640"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Lago, T.S., Silva, J.A., Lago, E.L., Carvalho, E.M., Zanette, D.L., and Castellucci, L.C. (2018). The miRNA 361-3p, a Regulator of GZMB and TNF Is Associated with Therapeutic Failure and Longer Time Healing of Cutaneous Leishmaniasis Caused by L. (Viannia) braziliensis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02621"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"de Mesquita, T.G.R., Junior, J.D.E.S., de Lacerda, T.C., Queiroz, K.L.G.D., J\u00fanior, C.M.d.S., Neto, J.P.d.M., Gomes, L.A.M., de Souza, M.L.G., Guerra, M.V.d.F., and Ramasawmy, R. (2021). Variants of mirna146a rs2910164 and mirna499 rs3746444 are associated with the development of cutaneous leishmaniasis caused by Leishmania guyanensis and with plasma chemokine il-8. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009795"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature13905","article-title":"MicroRNA silencing for cancer therapy targeted to the tumour microenvironment","volume":"518","author":"Cheng","year":"2015","journal-title":"Nature"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-907X-3-1","article-title":"Inhibition of microRNA function by antimiR oligonucleotides","volume":"3","author":"Stenvang","year":"2012","journal-title":"Silence"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mrfmmm.2011.03.004","article-title":"Extracellular microRNA: A new source of biomarkers","volume":"717","author":"Etheridge","year":"2011","journal-title":"Mutat. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1017\/S0031182021001177","article-title":"Highlighting the interplay of microRNAs from Leishmania parasites and infected-host cells","volume":"148","author":"Rashidi","year":"2021","journal-title":"Parasitology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/CMR.18.2.293-305.2005","article-title":"Subversion mechanisms by which Leishmania parasites can escape the host immune response: A signaling point of view","volume":"18","author":"Olivier","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1242\/jcs.056465","article-title":"An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages","volume":"123","author":"Silverman","year":"2010","journal-title":"J. Cell Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/AAC.45.3.913-916.2001","article-title":"Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate","volume":"45","author":"Demicheli","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0190-9622(94)70229-2","article-title":"Treatment of cutaneous leishmaniasis","volume":"31","author":"Koff","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002329900086","article-title":"Amphotericin B kills unicellular leishmanias by forming aqueous pores permeable to small cations and anions","volume":"152","author":"Ramos","year":"1996","journal-title":"J. Membr. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"taab065","DOI":"10.1093\/jtm\/taab065","article-title":"Efficacy and safety of pentamidine isethionate for tegumentary and visceral human leishmaniasis: A systematic review","volume":"28","author":"Piccica","year":"2021","journal-title":"J. Travel. Med."},{"key":"ref_82","unstructured":"Minist\u00e9rio da Sa\u00fade, Secretaria de Vigil\u00e2ncia em Sa\u00fade (2007). Manual de Vigil\u00e2ncia da Leishmaniose Tegumentar Americana: Serie A, Normas e Manuais T\u00e9cnicos."},{"key":"ref_83","unstructured":"World Health Organization (2010). Control of the Leishmanisases: Report of a Meeting of the WHO Expert Committee on the Control of Leishmanises, Geneva, 22\u201326 March 2010, World Health Organization."},{"key":"ref_84","unstructured":"Pan American Health Organization (2022). Guideline for the Treatment of Leishmaniasis in the Americas, Pan American Health Organization. [2nd ed.]. Available online: https:\/\/www.paho.org\/en\/documents\/guideline-treatment-leishmaniasis-americas-second-edition."},{"key":"ref_85","unstructured":"Pan American Health Organization (2020). Leishmaniasis: Epidemiological Report in the Americas, PAHO. Number 9, December 2020."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Castro, M.d.M., Cossio, A., Navas, A., Fernandez, O., Valderrama, L., Cuervo-Pardo, L., Marquez-O\u00f1ate, R., G\u00f3mez, M.A., and Saravia, N.G. (2022). Pentoxifylline in the Treatment of Cutaneous Leishmaniasis: A Randomized Clinical Trial in Colombia. Pathogens, 11.","DOI":"10.3390\/pathogens11030378"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Cincura, C., Costa, R.S., De Lima, C.M.F., Oliveira-Filho, J., Rocha, P.N., Carvalho, E.M., and Lessa, M.M. (2022). Assessment of Immune and Clinical Response in Patients with Mucosal Leishmaniasis Treated with Pentavalent Antimony and Pentoxifylline. Trop. Med. Infect. Dis., 7.","DOI":"10.3390\/tropicalmed7110383"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4269\/ajtmh.19-0139","article-title":"In situ cellular response underlying successful treatment of mucosal leishmaniasis with a combination of pentavalent antimonial and pentoxifylline","volume":"101","author":"Barbieri","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/511643","article-title":"Oral pentoxifylline combined with pentavalent antimony: A randomized trial for mucosal leishmaniasis","volume":"44","author":"Machado","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1164\/ajrccm.159.2.9804085","article-title":"Pentoxifylline inhibits TNF-\u03b1 production from human alveolar macrophages","volume":"159","author":"Marques","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1590\/S0074-02761996000200019","article-title":"Tumor Necrosis Factor-\u03b1 in Human American Tegumentary Leishmaniasis","volume":"91","author":"Coutinho","year":"1996","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1046\/j.0022-202x.2001.01600.x","article-title":"Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: Stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization","volume":"117","author":"Mann","year":"2001","journal-title":"J. Investig. Dermatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"5344085","DOI":"10.1155\/2022\/5344085","article-title":"Cutaneous Wound Healing: A Review about Innate Immune Response and Current Therapeutic Applications","volume":"2022","author":"Adib","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4269\/ajtmh.2005.73.79","article-title":"Successful treatment of refractory cutaneous leishmaniasis with GM-CSF and antimonials","volume":"73","author":"Almeida","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_95","first-page":"662","article-title":"Virtual screening of bioactive compounds: Concepts and aplications","volume":"41","author":"Piccirillo","year":"2018","journal-title":"Quim. Nova"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.2147\/IJN.S206109","article-title":"Advances in nanocarriers as drug delivery systems in chagas disease","volume":"14","author":"Quezada","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s13346-021-00908-7","article-title":"Current approaches in lipid-based nanocarriers for oral drug delivery","volume":"11","author":"Lozano","year":"2021","journal-title":"Drug Deliv. Transl. Res."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/2\/188\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:32:55Z","timestamp":1760027575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/2\/188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":97,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["pathogens14020188"],"URL":"https:\/\/doi.org\/10.3390\/pathogens14020188","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]}}}